MustGrow Biologics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for MustGrow Biologics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 15.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 0 | -5 | N/A | N/A | 1 |
12/31/2023 | 5 | -1 | 0 | 0 | N/A |
9/30/2023 | N/A | -5 | -4 | -4 | N/A |
6/30/2023 | 0 | -5 | -4 | -4 | N/A |
3/31/2023 | 0 | -6 | -3 | -3 | N/A |
12/31/2022 | 0 | -6 | -3 | -3 | N/A |
9/30/2022 | 0 | -6 | -3 | -3 | N/A |
6/30/2022 | 0 | -4 | -3 | -3 | N/A |
3/31/2022 | 0 | -3 | -3 | -3 | N/A |
12/31/2021 | 0 | -3 | -2 | -2 | N/A |
9/30/2021 | 0 | -3 | -2 | -2 | N/A |
6/30/2021 | N/A | -3 | -2 | -2 | N/A |
3/31/2021 | N/A | -3 | -2 | -2 | N/A |
12/31/2020 | N/A | -3 | -3 | -3 | N/A |
9/30/2020 | N/A | -3 | -2 | -2 | N/A |
6/30/2020 | N/A | -3 | -2 | -2 | N/A |
3/31/2020 | N/A | -2 | -2 | -2 | N/A |
12/31/2019 | N/A | -2 | -1 | -1 | N/A |
9/30/2019 | N/A | -1 | -1 | -1 | N/A |
6/30/2019 | N/A | -1 | -1 | -1 | N/A |
3/31/2019 | 0 | -1 | -1 | -1 | N/A |
12/31/2018 | 0 | -2 | -1 | -1 | N/A |
9/30/2018 | 0 | -2 | -1 | -1 | N/A |
6/30/2018 | 0 | -1 | -1 | -1 | N/A |
3/31/2018 | 0 | -1 | -1 | -1 | N/A |
12/31/2017 | 0 | 0 | 0 | 0 | N/A |
12/31/2016 | 0 | 0 | N/A | 0 | N/A |
12/31/2015 | 0 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MGRO's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if MGRO's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if MGRO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MGRO's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if MGRO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MGRO's Return on Equity is forecast to be high in 3 years time